 Dynavax Technologies Corp NASDAQ: DVAX is trading lower after the company announced Valneva SE NASDAQ: VALN received a termination notice from the United Kingdom government in relation to Valnevas supply agreement for its COVID-19 vaccine candidate, VLA2001. Valneva said it intends to continue clinical development of VLA2001, which is currently in Phase 3 trials. 